BP |
GO:0033363∼secretory granule organization |
2 |
1.44E-02 |
BP |
GO:0021983∼pituitary gland development |
2 |
1.44E-02 |
BP |
GO:0021536∼diencephalon development |
2 |
3.07E-02 |
MF |
GO:0001221∼transcription cofactor binding |
2 |
2.75E-03 |
MF |
GO:0000980∼RNA polymerase II distal enhancer sequence-specific DNA binding |
2 |
6.60E-03 |
MF |
GO:0001158∼enhancer sequence-specific DNA binding |
2 |
6.60E-03 |
MF |
GO:0035326∼enhancer binding |
2 |
6.60E-03 |
MF |
GO:0035497∼cAMP response element binding |
1 |
2.71E-02 |
MF |
GO:0001222∼transcription co-repressor binding |
1 |
2.71E-02 |
MF |
GO:0016780∼phosphotransferase activity, for other substituted phosphate groups |
1 |
2.94E-02 |
MF |
GO:0001223∼transcription coactivator binding |
1 |
3.06E-02 |
MF |
GO:0001228∼DNA-binding transcription activator activity, RNA polymerase II-specific |
2 |
3.06E-02 |
MF |
GO:0035035∼histone acetyltransferase binding |
1 |
3.13E-02 |
MF |
GO:0030544∼Hsp70 protein binding |
1 |
3.95E-02 |
MF |
GO:0018024∼histone-lysine N-methyltransferase activity |
1 |
3.95E-02 |
MF |
GO:0001102∼RNA polymerase II activating transcription factor binding |
1 |
4.10E-02 |
MF |
GO:0042054∼histone methyltransferase activity |
1 |
4.10E-02 |
MF |
GO:0016279∼protein-lysine N-methyltransferase activity |
1 |
4.10E-02 |
MF |
GO:0016278∼lysine N-methyltransferase activity |
1 |
4.10E-02 |
MF |
GO:0002039∼p53 binding |
1 |
4.17E-02 |
MF |
GO:0033613∼activating transcription factor binding |
1 |
4.91E-02 |
MF |
GO:0008276∼protein methyltransferase activity |
1 |
4.91E-02 |